Mateon Therapeutics (OTCMKTS:MATN) Stock Crosses Above Two Hundred Day Moving Average of $0.19

Share on StockTwits

Mateon Therapeutics Inc (OTCMKTS:MATN)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.19 and traded as high as $0.27. Mateon Therapeutics shares last traded at $0.27, with a volume of 100 shares changing hands.

MATN has been the topic of several research analyst reports. ValuEngine upgraded Mateon Therapeutics from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st. Zacks Investment Research downgraded Mateon Therapeutics from a “buy” rating to a “hold” rating in a research report on Tuesday, June 25th.

The business has a 50-day moving average of $0.25 and a 200 day moving average of $0.19.

Mateon Therapeutics (OTCMKTS:MATN) last posted its earnings results on Monday, August 19th. The biopharmaceutical company reported ($0.02) EPS for the quarter, hitting analysts’ consensus estimates of ($0.02). On average, analysts expect that Mateon Therapeutics Inc will post -0.06 EPS for the current fiscal year.

About Mateon Therapeutics (OTCMKTS:MATN)

Mateon Therapeutics, Inc, a clinical-stage biopharmaceutical, focuses on developing small molecule injectable drugs for the treatment of cancer. It is developing CA4P, an immuno-oncology agent that stimulates the immune system against the tumor; and OXi4503 for the treatment of relapsed/refractory acute myeloid leukemia.

Featured Article: What does a neutral rating on stocks mean?

Receive News & Ratings for Mateon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mateon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Gantzert Investment Co. LLC ADV Acquires Shares of 9,675 Raytheon
Gantzert Investment Co. LLC ADV Acquires Shares of 9,675 Raytheon
Epstein & White Financial LLC Has $1.02 Million Stock Position in Exxon Mobil Co.
Epstein & White Financial LLC Has $1.02 Million Stock Position in Exxon Mobil Co.
Epstein & White Financial LLC Trims Stake in iShares S&P 500 Value ETF
Epstein & White Financial LLC Trims Stake in iShares S&P 500 Value ETF
PepsiCo, Inc.  Shares Acquired by Gantzert Investment Co. LLC ADV
PepsiCo, Inc. Shares Acquired by Gantzert Investment Co. LLC ADV
Thor Industries, Inc.  Shares Purchased by Cim LLC
Thor Industries, Inc. Shares Purchased by Cim LLC
Ciena Co.  Director Sells $75,500.00 in Stock
Ciena Co. Director Sells $75,500.00 in Stock


 
© 2006-2019 Zolmax.